Hirsutism

    June 1990 in “ Postgraduate medicine ”
    Daniel L. Stulberg, Barbara S. Caruthers
    Studysummary This review highlights that pharmacologic therapy for hirsutism can effectively decrease hair growth, normalize menstrual cycles, and reduce endometrial cancer risk, with improvements in physical and mental well-being and minimal serious side effects reported.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Parenteral and Oral Cyproterone Acetate Treatment in Severe Hirsutism Gynecologic and obstetric investigation · 2010
    2. Side Effects of Spironolactone Therapy in the Hirsute Woman ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1988
    3. Hair Growth and Androgen Responses in Hirsute Women Treated with Continuous Cyproterone Acetate and Cyclical Ethinyl Estradiol European journal of endocrinology · 1987
    4. The Effects of Two Doses of Spironolactone on Serum Androgens and Anagen Hair in Hirsute Women Fertility and sterility · 1985
    5. Effects of a Low-Dose Desogestrel-Ethinylestradiol Combination on Hirsutism, Androgens, and Sex Hormone Binding Globulin in Women with Polycystic Ovary Syndrome Acta obstetricia et gynecologica Scandinavica · 1985
    6. 3 Alpha, 17 Beta-Androstanediol Glucuronide in Plasma: A Marker of Androgen Action in Idiopathic Hirsutism ˜The œJournal of clinical investigation/˜The œjournal of clinical investigation · 1982
    7. Treatment of Hirsutism With Spironolactone JAMA · 1982
    8. Evaluation of Hirsutism and Hyperandrogenemia Fertility and Sterility · 1981